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ated with a lower incidence of
food allergen sensitization in early
childhoodTo the Editor:
Sensitization to food allergens is increasing more rapidly than
sensitization to pollen or animal allergens.1,2 On a population
level, development of allergic sensitization commonly begins
with food allergen sensitization in early infancy, followed or
sometimes replaced by sensitization to animals and later, at 4 to
5 years of age, including sensitization to pollen.
The cause for the onset or development of sensitization to
allergens and allergy-related diseases is still not known.
Environmental and lifestyle factors are considered to contribute
to disease development.3 Anthroposophy is a holistic philosophy
that was founded by the Austrian philosopher Rudolf 2015 The Authors. Published by Elsevier, Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Steiner (1861-1925) and covers most aspects of life, including
education, health care, agriculture, and diet.4 Previous
cross-sectional studies have shown that Steiner school children,
who often come from families with an anthroposophic lifestyle,
have a lower prevalence of sensitization and allergic disease
compared with reference children.5,6 These observations have
been confirmed in the prospective birth cohort Assessment of
Lifestyle and Allergic Disease During Infancy (ALADDIN).7
In Hesla et al,8 we report the clinical manifestations up to
2 years of age in the ALADDIN cohort and provide a description
of demographics and early lifestyle exposures. We observed that
anthroposophic lifestyle was associated with a reduced risk of re-
ported food hypersensitivity and reported recurrent wheeze but
not eczema. Moreover, delayed washing of the newborn’s whole
body (after 7 days of age) was associated with a reduced risk of
allergen sensitization, whereas an increased risk was seen for
children who had a mother who worked during pregnancy. How-
ever, much of the effect of anthroposophic lifestyle on allergen
sensitization was unexplained. In this letter we report how the
association between lifestyle and sensitization to food, animal,
and pollen allergens differs with the child’s age.
For complete materials and methodology, see the Methods
section in this article’s Online Repository at www.jacionline.org.
Briefly, this study is based on the Swedish prospective cohort
ALADDIN,7 in which 552 children and their families were
followed using questionnaires, examinations, and blood samples.
The families were classified into 3 lifestyle groups (anthroposo-
phic, partly anthroposophic, and nonanthroposophic). Blood sam-
ples were collected from the children at 6, 12, 24, and 60 months
of age. Sensitization to food (hen’s egg, cow’smilk, and/or peanut),
animal (dog and/or cat), and pollen (birch and/or timothy) allergens
was determined. IgE values of 0.35 kUA/L or greater were regarded
as being sensitized. Incidence and prevalence of sensitization were
determined. The inclusion process and distribution of children and
available blood samples are presented in Fig E1 in this article’s On-
line Repository at www.jacionline.org, and prevalences of IgE
sensitization for the individual allergens are presented in
Table E1 in this article’s Online Repository at www.jacionline.
org. As described in Hesla et al,8 several demographic and early
lifestyle exposures differed between the lifestyle groups; however,
neither parental sensitization nor parental report of allergy-related
disease were associated with anthroposophic lifestyle. In addition,
parental sensitization was not associated with child sensitization.
Incidence proportions of sensitization for the different
allergen categories are presented in Fig 1, A to D. In the
nonanthroposophic group the incidence proportions of food
allergen sensitization were high up to 12 months of age: 15%
and 16% were first time sensitized for the age periods of 0 to 6
and 6 to 12 months, respectively, and then decreased to 5%
from 12 to 24 months to increase again to 16% from 24 to
60 months. In contrast, in the anthroposophic group the incidence
proportions of food sensitization were low at up to 12 months of
age and similar for the 4 age periods as follows: 1% (0 to
6 months), 1% (6-12 months), 8% (12-24 months), and 9% (24-
60months). In the partly anthroposophic group the incidence pro-
portions of food allergen sensitization were stable, around 7% for
all age periods. In all lifestyle groups sensitization to animal and
pollen allergens occurred later than to food allergens.
We used general estimating equation models to study the
interaction between age and lifestyle and found that age
significantly modified the association between lifestyle and
FIG 1. Incidence proportions (A-D) and point prevalences (E-H) of IgE sensitization (IgE >_0.35 kUA/L) to food
(cow’s milk, hen’s egg, and/or peanut), animal (dog and/or cat), and pollen (birch and/or timothy) allergens
in children of families with anthroposophic (green), partly anthroposophic (blue), and nonanthroposophic
(red) lifestyles.
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FIG 2. Association between lifestyle and prevalence of food, animal, and pollen allergen sensitization
at 6, 12, 24, and 60 months of age in ORs and 95% CIs from a generalized estimating equation model.
A, Anthroposophic; Partly A, partly anthroposophic; Non A, nonanthroposophic.
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association between anthroposophic lifestyle and food
allergen sensitization was stronger at 6, 12, and 24 months
(odds ratio [OR], 0.16, 0.18, and 0.25, respectively) than at
60 months (OR, 0.58). The association between partly
anthroposophic lifestyle and food allergen sensitization was
similar at all 4 ages (OR, 0.42, 0.41, 0.40, and 0.35, respectively).
No such interaction between age and lifestyle was observed
for animal (P 5 .89) or pollen (P 5 .91) allergen sensitization
(Fig 2).
The pattern of allergic sensitization, starting with sensitization
against food allergens and followed by animal and pollen allergen
sensitization, has been described earlier.9 However, few studies
have reported the prevalence of allergen sensitization in early
infancy.2 Tolerance to cow’s milk and hen’s egg usually develops
at 4 to 6 years of age.9,10 Because the prevalence of animal and
pollen sensitization was low in the present study, which is
expected at these ages,9 the association with lifestyle should be
interpreted with caution. However, our results are in accordance
with earlier studies of school-aged children in which the
association with anthroposophic lifestyle was significant only
for food but not inhalant allergen sensitization.5,6
A higher proportion of families in the anthroposophic group did
not consent to blood sampling. However, introduction of selection
bias is unlikely because this reluctance to participate in blood
sampling was likely to be related to lifestyle and not to
sensitization of the child or parent. Consent to blood sampling
was made before the parents received any results regarding their
own or the child’s blood sample analyses.
In conclusion, our findings suggest that the reduced prevalence
of allergen sensitization seen among children of families with an
anthroposophic lifestylewas largely explained by a low incidence
of food sensitization before 1 year of age. This indicates that
anthroposophic lifestyle has a greater effect on allergen
sensitization during the first year of life.We acknowledge the families participating in the ALADDIN study for their
trust and contribution and the ALADDIN team for their involvement in this
work, especially nurse and coordinator Margareta Eriksson, medical doctor
Fredrik Stenius, laboratory manager Catharina Johansson, and biomedical
analysts Monica Nordlund and Carina Wallen.
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cacy of CD32 to inhibit activation
of FcεRI in human basophilsTo the Editor:
The mechanisms that underlie the success of allergen
immunotherapy are varied, and the precise details remain unclear.
Immune deviation and blocking antibodies are 2 important
candidate explanations, and under the category of blocking
antibodies are 2 often discussed possibilities: (1) simple compe-
tition for allergen between IgG antibodies developed during
immunotherapy and IgE antibodies on the mast cell and basophil
cell surface (what we are calling stoichiometric blockade) or (2)
interaction between IgG antibodies and CD32 (the low-affinity
IgG receptor FcgRII) on mast cells1,2 or basophils,3-6 leading to
inhibition of the IgE-mediated response.
There is conflicting information about the role of CD32 in this
reaction in human subjects. One possible issue is whether
humanmast cells even express CD32b, the inhibitory IgG receptor.
Other issues relate to the relative ability of different IgG subclasses
to interact with CD32b or CD32a7 and whether CD32a, which is
normally considered an activating IgG receptor, acts in an
inhibitory capacity in the context of CD32b or cell type.4,5
Human basophils express both CD32a and CD32b,3-6 and it has
been clearly demonstrated that CD32 can mediate inhibition of
the IgE-dependent reaction. However, there are a variety of
studies that have demonstrated that not all IgG subclasses bind
to CD32a or CD32b.7 Also, there are polymorphisms in CD32
that influence binding and/or function to certain subclasses.7,8
Furthermore, immunotherapy generates different increases in
IgG subclasses, and for a variety of reasons, studies have focused
on IgG1 and IgG4 and very infrequently examine IgG2 or IgG3.
However, binding studies have shown that IgG4 does not
interact with CD32a or CD32b.7 What remains unclear is the
relative ability of IgG1, IgG2, and IgG3 to interact with CD32
and the potential for polymorphisms to further differentiate
binding.
Using partially enriched human basophils (see the Methods sec-
tion in this article’sOnlineRepository atwww.jacionline.org) and a
series of transfectoma antibodies all using the same complemen-
tarity determining region specific for nitrophenyl (NP) but varying
the heavy chain subclass (IgE, IgG1, IgG2, IgG3, and IgG4), the abil-
ity of the various IgG subclasses to inhibit IgE-mediated release
from basophils sensitized with NP-specific IgE was examined.
Three reaction designs were examined, holding IgG constant andvarying antigen (which is presumably that natural situation), hold-
ing allergen constant and varying IgG, and a third approach pre-
sented in the Results section in this article’s Online Repository
(see also Fig E1 in this article’s Online Repository at www.
jacionline.org for a schematic of the experimental design). Fig 1
shows results using the first 2 methods.
By using the first method, the amount of inhibition by IgG was
titrated to approximately 50% to detect alteration of the response in
either the positive or negative directionwhen including blockade of
CD32 and to not bias the reaction to complete stoichiometric
blocking (see the Results section in this article’s Online Reposi-
tory). To block CD32 and therefore test the involvement of
CD32-mediated inhibition rather than simple stoichiometric
blockade, an engineered high-affinity anti-CD32b antibody and a
commercial anti-CD32a antibody were used. The densities of
CD32a and CD32b were also monitored by using flow cytometry.
The results, focusing on the highest concentrations of antigen and
antibody (Fig 1, A-F), indicate that it was difficult to detect func-
tional interaction with CD32b when IgG1 was used, but IgG2 and
IgG3 effectively engaged CD32b (the degree of CD32b involve-
ment was measured by the extent of reversal of inhibition when
including the CD32b-blocking antibody Ab10523). At lower con-
centrations of antigen, only stoichiometric inhibition is observed.
Fig E2 in this article’s Online Repository at www.jacionline.org
shows the importance of absolute antigen concentration and the
importance of IgG/allergen ratios.
In the second design shown in Fig 1, G (holding antigen
constant and varying IgG), it can be again observed that IgG1
did not engage CD32b, whereas IgG2 and IgG3 did. As shown
in Fig E3 in this article’s Online Repository at www.jacionline.
org, IgG4 did not cause inhibition. These results also demon-
strated that IgG3 was 10-fold more efficacious in interacting
with CD32b than IgG2, such that only 1 IgG3 per 20 antigen
molecules was necessary to mediate inhibition, whereas
approximately 0.5:1 ratios were needed for IgG2. Fig 1, B, D,
and F, also examined the ability to further reverse inhibition
through inclusion of CD32a blockade with antibody AbIV.3
(see the Results section in this article’s Online Repository). There
was some further reversal by addition of AbIV.3, although the best
reversal occurred with CD32b blockade. As discussed in the
Results section in this article’s Online Repository, heterogeneity
in the relative participation of CD32 was correlated with CD32
expression (see Table E1 in this article’s Online Repository at
www.jacionline.org), and reversal of IgG2 and IgG3 was corre-
lated. Furthermore, as shown in Fig E4, polymorphisms in
CD32a and CD32b did not influence the relative participation
of CD32. As a low-affinity IgG receptor, CD32 is not thought
to engage monomeric IgG effectively, but concentrations of IgG
in plasma are very high, and therefore the ability of nonspecific
IgG (nsIgG) to inhibit participation of CD32 (by using nsIgG as
a substitute for Ab10523) was examined. Fig E5 in this article’s
Online Repository at www.jacionline.org shows that reversal of
CD32’s effects occur at an inhibitory concentration of 50% of
150 mg/mL nsIgG.
These and our previous studies6 suggest that there are several
important parameters, possibly 5 dimensions, which determine
whether it is possible to observe the inhibitory function of
CD32 on basophils (see also theDiscussion section in this article’s
Online Repository at www.jacionline.org). These results place
some constraints on how to explore the role of CD32 in the baso-
phil reaction during immunotherapy, and the variability in the
METHODS
Study population
This study is based on the prospective birth cohort ALADDIN.E1 The
families were recruited between September 2004 and November 2011 from
anthroposophic and conventional maternal-child health care centers (MCHCs)
in Stockholm and J€arna, a village situated south of Stockholm with a
community of anthroposophic followers. Parents were informed about the
study at their MCHC, and families interested in participation were enrolled.
A total of 552 families were recruited, of whom 444 were recruited during
pregnancy and 108 shortly after birth. Preterm infants (born before gestational
week 36) and miscarriages were excluded. The parents answered detailed
questionnaires about their daily life, health, and food, and the children were
examined repeatedly.E2 Inclusion criteria for children in the present study
were having a lifestyle classification (see below) and at least 1 (of 4) blood
samples taken (Fig E1). The study was approved by the local ethics committee
in Stockholm, and written informed consent was obtained from all parents.
Categorization into lifestyle groups
The families were classified into 3 lifestyle groups (anthroposophic, partly
anthroposophic, and nonanthroposophic) based on their choice of MCHC and
based on answers to 3 questionnaire questions: (1) ‘‘What kind of preschool/
school will your newborn child probably go to?’’; (2) ‘‘Has either of the
parents, no matter which type of school you have planned for your child, an
anthroposophic view of life?’’; and (3) ‘‘Is the family’s everyday life
influenced by an anthroposophic view of life?’’ Families answering
‘‘anthroposophic school’’ to question 1 and yes to questions 2 and 3 and
also attending anthroposophic MCHCs were defined as being anthroposophic.
Families answering ‘‘conventional’’ or any other nonanthroposophic type of
school to question 1, no to questions 2 and 3, and attending conventional
MCHCs were defined as being nonanthroposophic. Families with any other
combination of answers were defined as being partly anthroposophic.
Determination of allergen sensitization
Blood samples were collected in sodium heparin tubes from parents at the
time of inclusion and from the children at 6, 12, 24, and 60 months of age.
Plasma was stored at 2208C. Parental sensitization was determined by using
ImmunoCAP Phadiatop (Thermo Fisher Scientific, Uppsala, Sweden) for IgE
levels to a set of 11 inhalant allergens. Sensitization at 6, 12, and 24 months of
age was determined by using ImmunoCAP (Thermo Fisher Scientific) for IgE
levels to hen’s egg, cow’s milk, peanut, dog, cat, birch, and timothy.
Sensitization at 5 years of age was determined by using Phadiatop and a
food mix of cow’s milk, hen’s egg, fish, wheat, soybean, and peanut (fx5,
Thermo Fisher Scientific). Subjects with allergen-specific IgE levels of 0.35
kUA/L or greater were regarded as being sensitized. Allergens were
divided into 3 categories: food, animal, and pollen allergens. The analysis at
60 months was restricted to the same 7 allergens used at earlier time points
to obtain a comparable longitudinal observation of the development of
sensitization.
Statistical analysis
Incidence and prevalence were depicted graphically for the 3 allergen
categories, as well as for any sensitization, by lifestyle. Prevalence was
calculated as the number of sensitized children at each age through the number
of nonmissing observations at the respective age. Incidence proportions were
calculated as the number of first time–sensitized children (cases) during the
time period divided by the number of children at risk. The children with
missing previous samples were considered at risk for that time period, as long
as they had not previously been sensitized and had a nonmissing value for age
at the end of the time period. To evaluate whether the association between
lifestyle and prevalence of sensitization of the respective categories of
allergens varied with age, we used generalized estimating equation models
with an unstructured correlation matrix and included an interaction term
between lifestyle and age as a continuous variable. The significance level was
set at .05 (2-sided). Statistical analyses were performed with R v3.1.3 (R
Foundation for Statistical Computing, Vienna, Austria) and SAS v9.4 (SAS
Institute, Cary, NC) software.
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FIG E1. Flowchart of inclusion and number of available blood
samples at each time point for the children in relation to lifestyle. *At the
time of this study, 6 anthroposophic, 32 partly anthroposophic, and 21
nonanthroposophic children had not turned 5 years of age.
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TABLE E1. Point prevalence of IgE sensitization against different
allergens at 6, 12, 24, and 60 months of age in children from
families with anthroposophic, partly anthroposophic, and
nonanthroposophic lifestyles
Anthroposophic,
n/N (%)
Partly
anthroposophic
n/N (%)
Non-
anthroposophic,
n/N (%)
Sensitization at 6 mo
Any allergen* 2/71 (2.8) 14/160 (8.8) 25/139 (18)
Food* 1/75 (1.3) 12/172 (7.0) 22/143 (15.4)
Milk* 0 5 15
Egg 1 9 11
Peanut 0 3 2
Animal 1/71 (1.4) 3/160 (1.9) 7/139 (5.0)
Cat 1 2 4
Dog 0 1 3
Pollen 0/73 (0) 0/162 (0) 0/140 (0)
Birch 0 0 0
Timothy 0 0 0
Sensitization at 12 mo
Any allergen* 3/71 (4.2) 23/167 (13.8) 37/139 (26.6)
Food* 2/75 (2.7) 21/170 (12.4) 37/145 (25.5)
Milk* 0 11 17
Egg* 2 12 24
Peanut 0 7 6
Animal 1/70 (1.4) 4/167 (2.4) 8/137 (5.8)
Cat 1 2 5
Dog 0 2 5
Pollen 0/74 (0) 0/167 (0) 1/137 (0.7)
Birch 0 0 1
Timothy 0 0 1
Sensitization at 24 mo
Any allergen* 13/86 (15.1) 22/166 (13.3) 35/147 (23.8)
Food 8/86 (9.3) 19/169 (11.2) 27/148 (18.2)
Milk 8 16 19
Egg* 3 8 16
Peanut 0 8 7
Animal* 2/86 (2.3) 3/167 (1.8) 11/147 (7.5)
Cat 2 2 8
Dog* 0 3 8
Pollen 4/86 (4.7) 6/166 (3.6) 9/148 (6.1)
Birch 4 5 6
Timothy 0 2 5
Sensitization at 60 mo
Any allergen* 14/68 (20.6) 22/123 (17.9) 37/97 (38.1)
Food* 8/68 (11.8) 11/123 (8.9) 28/97 (28.9)
Milk* 5 7 22
Egg* 6 3 14
Peanut* 2 3 9
Animal* 3/68 (4.4) 7/123 (5.7) 15/97 (15.5)
Cat* 3 5 12
Dog* 2 5 11
Pollen 9/68 (13.2) 12/123 (9.8) 16/97 (16.5)
Birch 8 9 9
Timothy 5 10 13
*Differences were significant at P values of less than .05.
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